Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced.

Most European travellers heading to sub-tropical regions know to make sure they're up to date on their vaccinations. While ...

The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...

Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...

Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA) has lifted the suspension on its chikungunya ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address ...